North Carolina Biotechnology Center
The North Carolina Biotechnology Center (NCBiotech) is a private, nonprofit corporation established in 1984 by the state and supported by the North Carolina General Assembly. Headquartered in Research Triangle Park, North Carolina, the organization operates statewide with 88-91 employees. NCBiotech is classified as a 501(c)(3) organization and functions as a life science economic development organization.
Financial Overview
From 2024 IRS Form 990-PF · View filing
Total Assets
$44.0M
-0.2% YoY
Annual Giving
$4.2M
+93.5% YoY
Grant Count
41
+156.3% YoY
Avg Grant Size
$103K
-24.5% YoY
Mission & Focus Areas
NCBiotech's mission is to transform North Carolina into a global life science leader and advance life science technology-based economic development through innovation, commercialization, education, and business growth.
The organization's primary program areas include:
Science and Technology Development: Strengthens the state's infrastructure for life science research through support to state universities, colleges, and nonprofit institutions. The program has provided over $145 million since 1984 to enhance research and intellectual capabilities.
Commercialization Program: Combines science and technology development with emerging company development to support bioscience companies.
Sector Development: Operates a conference center as an event space solution for life science companies.
The organization's work focuses on biological and life science research (NTEE code U50).
Grantmaking
NCBiotech provides funding through grants and loans to researchers, businesses, universities, and nonprofit institutions.
Grant Range
s:**
Grant Types
Ready to take the next step with North Carolina Biotechnology Center?
Geographic Focus
Where this funder awards grants
NCBiotech primarily funds within North Carolina, though grant-making also extends to New York and Georgia.
Grant Distribution by State
Cities
Financial History
Multi-year comparison from IRS filings
Assets and Revenue (Fiscal Year 2024):
- Total assets: $44,048,241
- Total revenues: $23,117,302
- Total expenses: $24,027,592
- Total giving: $8,040,739
Historical Financial Data (Fiscal Year 2023):
- Revenue: $21.9 million
- Expenses: $18.5 million
- Total assets: $44.1 million
- Total liabilities: $1.03 million
Tax Status: Tax-exempt since May 1985 (EIN: 56-1434024)
Rating: NCBiotech holds a Four-Star rating with a 96% overall score based on Accountability & Finance metrics.
| Metric | 2024 | 2023 | 2022 |
|---|---|---|---|
| Total Assets | $44,048,241 | $44,128,955 | $40,603,397 |
| Revenue | $23,117,302 | $21,886,317 | $19,911,762 |
| Expenses | $24,027,592 | $18,520,073 | $16,365,269 |
| Qualifying Distributions | — | — | — |
| Net Investment Income | $254,168 | $1,096,636 | $148,054 |
| Distributable Amount | — | — | — |
Giving Over Time
Total grant dollars and number of grants per year
Grant Insights
How this funder distributes its grants
Top Recipients
Top 10 recipients in 2024
Grant Size Distribution
110 grants across all recorded years
Open Grants
6 open opportunities from North Carolina Biotechnology Center
Event Grants
NORTH CAROLINA BIOTECHNOLOGY CENTER
Amount
Varies
Deadline
Rolling / Open
Flash Grant
NORTH CAROLINA BIOTECHNOLOGY CENTER
Amount
$30,000 - $37,500
Deadline
July 15, 2026
Innovation Impact Grant (IIG)
NORTH CAROLINA BIOTECHNOLOGY CENTER
Amount
$150,000
Deadline
September 30, 2026
Giving History
Grant recipients and amounts by year
No grants recorded for .
Leadership & Key People
Officers and directors from IRS filings
Compensation Overview
From 2024 IRS filing
From 2024 filing
| Name | Title | Hours | Compensation |
|---|---|---|---|
| SANTO COSTA | CHAIR | 2 | — |
| MEREDITH FRIGA | VICE CHAIR AND TREASURER | 2 | — |
| PEYTON ANDERSON | SECRETARY | 2 | — |
| DOUG EDGETON | PRESIDENT & CEO/ASST BOD SECRETARY | 40 | $342,570 |
| REBECCA ALEXANDER | DIRECTOR | 1 | — |
| JOHN ANTHONY ATALA | DIRECTOR | 1 | — |
| JOHN ATKINS III | DIRECTOR | 2 | — |
| MICHELLE BERREY | DIRECTOR | 2 | — |
| JAMES DATIN | DIRECTOR | 1 | — |
| JOY PARR DRACH | DIRECTOR | 2 | — |
| NEAL FOWLER | DIRECTOR | 1 | — |
| KELLY FULLER | DIRECTOR | 1 | — |
| PENNY GORDON-LARSEN | DIRECTOR | 1 | — |
| MICHELLE GRAINGER | DIRECTOR | 1 | — |
| WILLIAM HAWKINS III | DIRECTOR | 1 | — |
| UNDI HOFFLER | DIRECTOR | 1 | — |
| DAN JANIES | DIRECTOR | 1 | — |
| SHAYLAH NUNN JONES | DIRECTOR | 1 | — |
| KAREN LEVERT | DIRECTOR | 2 | — |
| JENNIFER LODGE | DIRECTOR | 1 | — |
| MICHELLE LOGAN | DIRECTOR | 1 | — |
| STEVE LOMMEL | DIRECTOR | 2 | — |
| JOHN LOYACK | DIRECTOR | 1 | — |
| MERRILL MASON | DIRECTOR | 2 | — |
| SHEILA MIKHAIL | DIRECTOR | 1 | — |
| TIM MINOR | DIRECTOR | 1 | — |
| ADAM MONROE | DIRECTOR | 1 | — |
| ARTHUR PAPPAS | DIRECTOR | 2 | — |
| SHARON PAYNTER | DIRECTOR | 1 | — |
| JOHN RABBY | DIRECTOR | 2 | — |
| MACHELLE BAKER SANDERS | DIRECTOR | 1 | — |
| MICHAEL TANNER | DIRECTOR | 1 | — |
| BEN TEAGUE | DIRECTOR | 1 | — |
| STEVE TROXLER | DIRECTOR | 1 | — |
| BHASKAR VENEPALLI | DIRECTOR | 1 | — |
| ASWANI VOLETY | DIRECTOR | 1 | — |
| THOMAS WALKER | DIRECTOR | 1 | — |
| BRAD WILSON | DIRECTOR | 1 | — |
| BENJAMIN YERXA | DIRECTOR | 1 | — |
| JAMES BULLOCK | VP FINANCE/ASST BOD TREASURER | 40 | $150,417 |
| MARY BETH THOMAS | SR VP, SCIENCE & BUSINESS DEV | 40 | $199,544 |
| WILLIAM BULLOCK | SR VP, ECON & STATEWIDE DEV | 40 | $199,544 |
| MARY HECHT-KISSELL | VP, CORPORATE COMMUNICATIONS | 40 | $151,293 |
| MARK PHILLIPS | VP, STATEWIDE OPERATIONS | 40 | $163,296 |
| ROBERT LINDBERG | VP, SCIENCE & TECH DEV | 40 | $163,136 |
| LAURA ROWLEY | VP, LIFE SCIENCE ECON DEV | 40 | $151,639 |
| JOSEPH HENDERSON | VP, TALENT & CULTURE DEV | 40 | $150,619 |
Recent News & Activity
Recent developments and announcements
Received a $25 million federal grant as lead organization of a statewide coalition of public and private partner organizations and institutions (September 2022)
Continued quarterly grant and loan distributions throughout 2022-2024
Supported multiple startup companies in the life sciences sector including cultivated protein technology, gene therapy, and molecular farming ventures
Subject Areas
Focus areas based on grantmaking activity
Data last updated April 2026. Sourced from IRS Form 990-PF filings. Research dossier generated April 2026.
What could you do with North Carolina Biotechnology Center on Grantable?
- Assess strategic fit with your organization
- Draft a tailored letter of inquiry
- Find open RFPs from this funder
- Monitor for new funding opportunities